1 Market Overview
1.1 Product Overview and Scope of Metabotropic Glutamate Antagonists
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Metabotropic Glutamate Antagonists Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ionic
1.3.3 Non Ionic
1.4 Market Analysis by Application
1.4.1 Overview: Global Metabotropic Glutamate Antagonists Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals And Clinics
1.4.3 Research Institutes
1.4.4 Others
1.5 Global Metabotropic Glutamate Antagonists Market Size & Forecast
1.5.1 Global Metabotropic Glutamate Antagonists Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Metabotropic Glutamate Antagonists Sales Quantity (2018-2029)
1.5.3 Global Metabotropic Glutamate Antagonists Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Artemis Neuroscience
2.1.1 Artemis Neuroscience Details
2.1.2 Artemis Neuroscience Major Business
2.1.3 Artemis Neuroscience Metabotropic Glutamate Antagonists Product and Services
2.1.4 Artemis Neuroscience Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Artemis Neuroscience Recent Developments/Updates
2.2 VistaGen Therapeutics
2.2.1 VistaGen Therapeutics Details
2.2.2 VistaGen Therapeutics Major Business
2.2.3 VistaGen Therapeutics Metabotropic Glutamate Antagonists Product and Services
2.2.4 VistaGen Therapeutics Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 VistaGen Therapeutics Recent Developments/Updates
2.3 Rottapharm Madaus
2.3.1 Rottapharm Madaus Details
2.3.2 Rottapharm Madaus Major Business
2.3.3 Rottapharm Madaus Metabotropic Glutamate Antagonists Product and Services
2.3.4 Rottapharm Madaus Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Rottapharm Madaus Recent Developments/Updates
2.4 Amorsa Therapeutics
2.4.1 Amorsa Therapeutics Details
2.4.2 Amorsa Therapeutics Major Business
2.4.3 Amorsa Therapeutics Metabotropic Glutamate Antagonists Product and Services
2.4.4 Amorsa Therapeutics Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Amorsa Therapeutics Recent Developments/Updates
2.5 Newron Pharmaceuticals
2.5.1 Newron Pharmaceuticals Details
2.5.2 Newron Pharmaceuticals Major Business
2.5.3 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product and Services
2.5.4 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Newron Pharmaceuticals Recent Developments/Updates
2.6 Purdue Biopharma
2.6.1 Purdue Biopharma Details
2.6.2 Purdue Biopharma Major Business
2.6.3 Purdue Biopharma Metabotropic Glutamate Antagonists Product and Services
2.6.4 Purdue Biopharma Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Purdue Biopharma Recent Developments/Updates
2.7 Relmada Therapeutics
2.7.1 Relmada Therapeutics Details
2.7.2 Relmada Therapeutics Major Business
2.7.3 Relmada Therapeutics Metabotropic Glutamate Antagonists Product and Services
2.7.4 Relmada Therapeutics Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Relmada Therapeutics Recent Developments/Updates
2.8 BioCrea GmbH
2.8.1 BioCrea GmbH Details
2.8.2 BioCrea GmbH Major Business
2.8.3 BioCrea GmbH Metabotropic Glutamate Antagonists Product and Services
2.8.4 BioCrea GmbH Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BioCrea GmbH Recent Developments/Updates
2.9 Cerecor Inc.
2.9.1 Cerecor Inc. Details
2.9.2 Cerecor Inc. Major Business
2.9.3 Cerecor Inc. Metabotropic Glutamate Antagonists Product and Services
2.9.4 Cerecor Inc. Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cerecor Inc. Recent Developments/Updates
2.10 NeurOp Inc.
2.10.1 NeurOp Inc. Details
2.10.2 NeurOp Inc. Major Business
2.10.3 NeurOp Inc. Metabotropic Glutamate Antagonists Product and Services
2.10.4 NeurOp Inc. Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NeurOp Inc. Recent Developments/Updates
2.11 UCB SA
2.11.1 UCB SA Details
2.11.2 UCB SA Major Business
2.11.3 UCB SA Metabotropic Glutamate Antagonists Product and Services
2.11.4 UCB SA Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 UCB SA Recent Developments/Updates
2.12 Novartis AG
2.12.1 Novartis AG Details
2.12.2 Novartis AG Major Business
2.12.3 Novartis AG Metabotropic Glutamate Antagonists Product and Services
2.12.4 Novartis AG Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis AG Recent Developments/Updates
2.13 Luc Therapeutics Inc.
2.13.1 Luc Therapeutics Inc. Details
2.13.2 Luc Therapeutics Inc. Major Business
2.13.3 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product and Services
2.13.4 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Luc Therapeutics Inc. Recent Developments/Updates
2.14 Evotec AG
2.14.1 Evotec AG Details
2.14.2 Evotec AG Major Business
2.14.3 Evotec AG Metabotropic Glutamate Antagonists Product and Services
2.14.4 Evotec AG Metabotropic Glutamate Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Evotec AG Recent Developments/Updates
3 Competitive Environment: Metabotropic Glutamate Antagonists by Manufacturer
3.1 Global Metabotropic Glutamate Antagonists Sales Quantity by Manufacturer (2018-2023)
3.2 Global Metabotropic Glutamate Antagonists Revenue by Manufacturer (2018-2023)
3.3 Global Metabotropic Glutamate Antagonists Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Metabotropic Glutamate Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Metabotropic Glutamate Antagonists Manufacturer Market Share in 2022
3.4.2 Top 6 Metabotropic Glutamate Antagonists Manufacturer Market Share in 2022
3.5 Metabotropic Glutamate Antagonists Market: Overall Company Footprint Analysis
3.5.1 Metabotropic Glutamate Antagonists Market: Region Footprint
3.5.2 Metabotropic Glutamate Antagonists Market: Company Product Type Footprint
3.5.3 Metabotropic Glutamate Antagonists Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Metabotropic Glutamate Antagonists Market Size by Region
4.1.1 Global Metabotropic Glutamate Antagonists Sales Quantity by Region (2018-2029)
4.1.2 Global Metabotropic Glutamate Antagonists Consumption Value by Region (2018-2029)
4.1.3 Global Metabotropic Glutamate Antagonists Average Price by Region (2018-2029)
4.2 North America Metabotropic Glutamate Antagonists Consumption Value (2018-2029)
4.3 Europe Metabotropic Glutamate Antagonists Consumption Value (2018-2029)
4.4 Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value (2018-2029)
4.5 South America Metabotropic Glutamate Antagonists Consumption Value (2018-2029)
4.6 Middle East and Africa Metabotropic Glutamate Antagonists Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
5.2 Global Metabotropic Glutamate Antagonists Consumption Value by Type (2018-2029)
5.3 Global Metabotropic Glutamate Antagonists Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
6.2 Global Metabotropic Glutamate Antagonists Consumption Value by Application (2018-2029)
6.3 Global Metabotropic Glutamate Antagonists Average Price by Application (2018-2029)
7 North America
7.1 North America Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
7.2 North America Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
7.3 North America Metabotropic Glutamate Antagonists Market Size by Country
7.3.1 North America Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2029)
7.3.2 North America Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
8.2 Europe Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
8.3 Europe Metabotropic Glutamate Antagonists Market Size by Country
8.3.1 Europe Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2029)
8.3.2 Europe Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Metabotropic Glutamate Antagonists Market Size by Region
9.3.1 Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
10.2 South America Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
10.3 South America Metabotropic Glutamate Antagonists Market Size by Country
10.3.1 South America Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2029)
10.3.2 South America Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Metabotropic Glutamate Antagonists Market Size by Country
11.3.1 Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Metabotropic Glutamate Antagonists Market Drivers
12.2 Metabotropic Glutamate Antagonists Market Restraints
12.3 Metabotropic Glutamate Antagonists Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Metabotropic Glutamate Antagonists and Key Manufacturers
13.2 Manufacturing Costs Percentage of Metabotropic Glutamate Antagonists
13.3 Metabotropic Glutamate Antagonists Production Process
13.4 Metabotropic Glutamate Antagonists Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Metabotropic Glutamate Antagonists Typical Distributors
14.3 Metabotropic Glutamate Antagonists Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Metabotropic Glutamate Antagonists Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Metabotropic Glutamate Antagonists Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Artemis Neuroscience Basic Information, Manufacturing Base and Competitors
Table 4. Artemis Neuroscience Major Business
Table 5. Artemis Neuroscience Metabotropic Glutamate Antagonists Product and Services
Table 6. Artemis Neuroscience Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Artemis Neuroscience Recent Developments/Updates
Table 8. VistaGen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. VistaGen Therapeutics Major Business
Table 10. VistaGen Therapeutics Metabotropic Glutamate Antagonists Product and Services
Table 11. VistaGen Therapeutics Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. VistaGen Therapeutics Recent Developments/Updates
Table 13. Rottapharm Madaus Basic Information, Manufacturing Base and Competitors
Table 14. Rottapharm Madaus Major Business
Table 15. Rottapharm Madaus Metabotropic Glutamate Antagonists Product and Services
Table 16. Rottapharm Madaus Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Rottapharm Madaus Recent Developments/Updates
Table 18. Amorsa Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Amorsa Therapeutics Major Business
Table 20. Amorsa Therapeutics Metabotropic Glutamate Antagonists Product and Services
Table 21. Amorsa Therapeutics Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Amorsa Therapeutics Recent Developments/Updates
Table 23. Newron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Newron Pharmaceuticals Major Business
Table 25. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product and Services
Table 26. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Newron Pharmaceuticals Recent Developments/Updates
Table 28. Purdue Biopharma Basic Information, Manufacturing Base and Competitors
Table 29. Purdue Biopharma Major Business
Table 30. Purdue Biopharma Metabotropic Glutamate Antagonists Product and Services
Table 31. Purdue Biopharma Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Purdue Biopharma Recent Developments/Updates
Table 33. Relmada Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Relmada Therapeutics Major Business
Table 35. Relmada Therapeutics Metabotropic Glutamate Antagonists Product and Services
Table 36. Relmada Therapeutics Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Relmada Therapeutics Recent Developments/Updates
Table 38. BioCrea GmbH Basic Information, Manufacturing Base and Competitors
Table 39. BioCrea GmbH Major Business
Table 40. BioCrea GmbH Metabotropic Glutamate Antagonists Product and Services
Table 41. BioCrea GmbH Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BioCrea GmbH Recent Developments/Updates
Table 43. Cerecor Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Cerecor Inc. Major Business
Table 45. Cerecor Inc. Metabotropic Glutamate Antagonists Product and Services
Table 46. Cerecor Inc. Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cerecor Inc. Recent Developments/Updates
Table 48. NeurOp Inc. Basic Information, Manufacturing Base and Competitors
Table 49. NeurOp Inc. Major Business
Table 50. NeurOp Inc. Metabotropic Glutamate Antagonists Product and Services
Table 51. NeurOp Inc. Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. NeurOp Inc. Recent Developments/Updates
Table 53. UCB SA Basic Information, Manufacturing Base and Competitors
Table 54. UCB SA Major Business
Table 55. UCB SA Metabotropic Glutamate Antagonists Product and Services
Table 56. UCB SA Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. UCB SA Recent Developments/Updates
Table 58. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 59. Novartis AG Major Business
Table 60. Novartis AG Metabotropic Glutamate Antagonists Product and Services
Table 61. Novartis AG Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis AG Recent Developments/Updates
Table 63. Luc Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Luc Therapeutics Inc. Major Business
Table 65. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product and Services
Table 66. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Luc Therapeutics Inc. Recent Developments/Updates
Table 68. Evotec AG Basic Information, Manufacturing Base and Competitors
Table 69. Evotec AG Major Business
Table 70. Evotec AG Metabotropic Glutamate Antagonists Product and Services
Table 71. Evotec AG Metabotropic Glutamate Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Evotec AG Recent Developments/Updates
Table 73. Global Metabotropic Glutamate Antagonists Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Metabotropic Glutamate Antagonists Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Metabotropic Glutamate Antagonists Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Metabotropic Glutamate Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Metabotropic Glutamate Antagonists Production Site of Key Manufacturer
Table 78. Metabotropic Glutamate Antagonists Market: Company Product Type Footprint
Table 79. Metabotropic Glutamate Antagonists Market: Company Product Application Footprint
Table 80. Metabotropic Glutamate Antagonists New Market Entrants and Barriers to Market Entry
Table 81. Metabotropic Glutamate Antagonists Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Metabotropic Glutamate Antagonists Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Metabotropic Glutamate Antagonists Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Metabotropic Glutamate Antagonists Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Metabotropic Glutamate Antagonists Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Metabotropic Glutamate Antagonists Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Metabotropic Glutamate Antagonists Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Metabotropic Glutamate Antagonists Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Metabotropic Glutamate Antagonists Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Metabotropic Glutamate Antagonists Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Metabotropic Glutamate Antagonists Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Metabotropic Glutamate Antagonists Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Metabotropic Glutamate Antagonists Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Metabotropic Glutamate Antagonists Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Metabotropic Glutamate Antagonists Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Metabotropic Glutamate Antagonists Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Metabotropic Glutamate Antagonists Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Metabotropic Glutamate Antagonists Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Metabotropic Glutamate Antagonists Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Metabotropic Glutamate Antagonists Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Metabotropic Glutamate Antagonists Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Metabotropic Glutamate Antagonists Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Metabotropic Glutamate Antagonists Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Metabotropic Glutamate Antagonists Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Metabotropic Glutamate Antagonists Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Metabotropic Glutamate Antagonists Raw Material
Table 141. Key Manufacturers of Metabotropic Glutamate Antagonists Raw Materials
Table 142. Metabotropic Glutamate Antagonists Typical Distributors
Table 143. Metabotropic Glutamate Antagonists Typical Customers
List of Figures
Figure 1. Metabotropic Glutamate Antagonists Picture
Figure 2. Global Metabotropic Glutamate Antagonists Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Type in 2022
Figure 4. Ionic Examples
Figure 5. Non Ionic Examples
Figure 6. Global Metabotropic Glutamate Antagonists Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Application in 2022
Figure 8. Hospitals And Clinics Examples
Figure 9. Research Institutes Examples
Figure 10. Others Examples
Figure 11. Global Metabotropic Glutamate Antagonists Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Metabotropic Glutamate Antagonists Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Metabotropic Glutamate Antagonists Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Metabotropic Glutamate Antagonists Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Metabotropic Glutamate Antagonists Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Metabotropic Glutamate Antagonists by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Metabotropic Glutamate Antagonists Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Metabotropic Glutamate Antagonists Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Metabotropic Glutamate Antagonists Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Metabotropic Glutamate Antagonists Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Metabotropic Glutamate Antagonists Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Metabotropic Glutamate Antagonists Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Metabotropic Glutamate Antagonists Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Metabotropic Glutamate Antagonists Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Metabotropic Glutamate Antagonists Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Metabotropic Glutamate Antagonists Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Metabotropic Glutamate Antagonists Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Metabotropic Glutamate Antagonists Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Metabotropic Glutamate Antagonists Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Metabotropic Glutamate Antagonists Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Metabotropic Glutamate Antagonists Consumption Value Market Share by Region (2018-2029)
Figure 53. China Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Metabotropic Glutamate Antagonists Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Metabotropic Glutamate Antagonists Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Metabotropic Glutamate Antagonists Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Metabotropic Glutamate Antagonists Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Metabotropic Glutamate Antagonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Metabotropic Glutamate Antagonists Market Drivers
Figure 74. Metabotropic Glutamate Antagonists Market Restraints
Figure 75. Metabotropic Glutamate Antagonists Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Antagonists in 2022
Figure 78. Manufacturing Process Analysis of Metabotropic Glutamate Antagonists
Figure 79. Metabotropic Glutamate Antagonists Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
